A Rare Case of Co-Existing Mucin-Producing Urothelial-Type Adenocarcinoma of the Prostate and Acinar Adenocarcinoma

医学 腺癌 前列腺 病理 膀胱前列腺切除术 前列腺切除术 旁侵犯 前列腺尿道 泌尿科 癌症 内科学
作者
Luiz M. Nova‐Camacho,Ainara Villafruela Mateos
出处
期刊:International Journal of Surgical Pathology [SAGE Publishing]
卷期号:31 (5): 627-633 被引量:2
标识
DOI:10.1177/10668969221105624
摘要

Mucin-producing urothelial-type adenocarcinoma of the prostate is an extremely rare neoplasm, and its coexistence with acinar adenocarcinoma is exceptional. A 70-year-old man presented with treatment resistant symptoms of urinary obstruction. The serum prostate specific antigen (PSA) level was normal. Cystoscopy revealed a kind of "cottony fluff" in the prostatic urethra. A computed tomography (CT) scan and magnetic resonance imaging (MRI) showed a polylobulated, hyperintense lesion with mucinous content. It was located in the right lobe of the prostate and measured 35 × 27 × 35 mm. The bladder cavity did not show lesions and the gastrointestinal endoscopy was normal. Thus, the patient underwent a radical cystoprostatectomy. The histological sections showed the characteristics of a mucin-producing adenocarcinoma with extensive areas of mucin pools formation. No areas of necrosis, glandular urethritis, or carcinoma in situ were identified. Neither lymphovascular and perineural invasion nor lymph node metastases were identified. The immunohistochemical study showed diffuse positivity for keratin (KRT) 7, KRT20, and membranous beta-catenin and focal positivity for KRT34betaE12 and caudal-related homeobox gene 2 (CDX2). In addition, we identified a 10-mm focus of prostatic acinar adenocarcinoma that was positive for racemase and NKX3.1. There is no treatment algorithm for this condition; however, surgery (radical prostatectomy) with or without adjuvant chemotherapeutic treatment represents a therapeutic alternative.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
林夕水函发布了新的文献求助10
刚刚
缓慢笑珊完成签到,获得积分10
刚刚
要减肥芫完成签到,获得积分10
刚刚
1秒前
1秒前
keplek完成签到,获得积分10
1秒前
liberal完成签到 ,获得积分10
2秒前
赘婿应助无奈的道天采纳,获得10
2秒前
千逐发布了新的文献求助10
2秒前
我是老大应助CJW采纳,获得10
3秒前
完美晓霜发布了新的文献求助10
3秒前
3秒前
冻干粉发布了新的文献求助10
4秒前
查亮亮发布了新的文献求助10
4秒前
想想发布了新的文献求助10
4秒前
5秒前
萌酱发布了新的文献求助10
5秒前
禧xi完成签到,获得积分10
5秒前
6秒前
小王同学完成签到,获得积分10
6秒前
6秒前
谦谦发布了新的文献求助10
6秒前
狂炫AD钙奶完成签到,获得积分10
6秒前
6秒前
keplek发布了新的文献求助10
7秒前
可爱的妙菡完成签到,获得积分10
7秒前
8秒前
8秒前
年轻怀绿完成签到,获得积分10
8秒前
z啦完成签到,获得积分10
8秒前
落雁完成签到,获得积分10
8秒前
8秒前
9秒前
9秒前
lilei发布了新的文献求助10
9秒前
Panjiao发布了新的文献求助20
9秒前
张惠兰完成签到,获得积分10
9秒前
mirror应助romy采纳,获得10
9秒前
搞怪的水彤完成签到 ,获得积分10
9秒前
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Handbook of pharmaceutical excipients, Ninth edition 5000
Aerospace Standards Index - 2026 ASIN2026 3000
Signals, Systems, and Signal Processing 610
Discrete-Time Signals and Systems 610
Principles of town planning : translating concepts to applications 500
Modified letrozole versus GnRH antagonist protocols in ovarian aging women for IVF: An Open-Label, Multicenter, Randomized Controlled Trial 360
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 纳米技术 有机化学 物理 生物化学 化学工程 计算机科学 复合材料 内科学 催化作用 光电子学 物理化学 电极 冶金 遗传学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 6062452
求助须知:如何正确求助?哪些是违规求助? 7894626
关于积分的说明 16310282
捐赠科研通 5205856
什么是DOI,文献DOI怎么找? 2785015
邀请新用户注册赠送积分活动 1767644
关于科研通互助平台的介绍 1647422